Actively Recruiting

Phase 3
Age: 12Years - 75Years
All Genders
NCT06750289

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

Led by AstraZeneca · Updated on 2026-05-13

400

Participants Needed

160

Research Sites

188 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with medium-dose ICS-LABA compared to the conventional treatment step of escalation of inhaled therapy to high-dose ICS-LABA.

CONDITIONS

Official Title

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

Who Can Participate

Age: 12Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Provided written informed consent
  • Age between 12 and 75 years
  • Diagnosed with asthma by a physician requiring at least medium-dose ICS (over 250 mcg fluticasone daily) plus LABA for at least 12 months
  • Treated with medium-dose ICS and LABA for at least 3 months prior to first visit, with or without other asthma controllers except oral corticosteroids
  • Body weight of 35 kg or more
  • Pre-bronchodilator FEV1 of 90% predicted or less
  • At least 2 asthma exacerbations in the 12 months before informed consent
  • Asthma Control Questionnaire (ACQ-6) score of 1.5 or higher at first visit and during run-in period
  • Evidence of asthma shown by variable lung function
  • Peripheral blood eosinophil count of 150 cells/µL or higher
  • At least 70% adherence to usual ICS-LABA treatment during run-in based on asthma diary
Not Eligible

You will not qualify if you...

  • Presence of significant lung disease other than asthma or systemic diseases raising eosinophil counts
  • Asthma exacerbation needing systemic corticosteroids or respiratory infection requiring antibiotics/antivirals within 30 days before consent or during screening
  • Any unstable medical condition affecting study participation as judged by investigator
  • Current serious infections needing systemic treatment
  • Participation in another clinical trial involving investigational products or safety studies
  • History of alcohol or drug abuse in the past 12 months
  • Current smokers or former smokers with 10 or more pack-years smoking history; former smokers must have quit at least 6 months before first visit

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 160 locations

1

Research Site

Chandler, Arizona, United States, 85224

Withdrawn

2

Research Site

Sun City, Arizona, United States, 85351

Actively Recruiting

3

Research Site

Tucson, Arizona, United States, 85704

Actively Recruiting

4

Research Site

Bakersfield, California, United States, 93301

Not Yet Recruiting

5

Research Site

Inglewood, California, United States, 90301

Actively Recruiting

6

Research Site

Modesto, California, United States, 95355

Not Yet Recruiting

7

Research Site

Newport Beach, California, United States, 92663

Actively Recruiting

8

Research Site

Pasadena, California, United States, 91101

Actively Recruiting

9

Research Site

Denver, Colorado, United States, 80206

Withdrawn

10

Research Site

Cape Coral, Florida, United States, 33990

Actively Recruiting

11

Research Site

Hialeah, Florida, United States, 33015

Not Yet Recruiting

12

Research Site

Lauderdale Lakes, Florida, United States, 33313

Actively Recruiting

13

Research Site

Leesburg, Florida, United States, 34748

Actively Recruiting

14

Research Site

Miami, Florida, United States, 33122

Not Yet Recruiting

15

Research Site

Miami, Florida, United States, 33155

Not Yet Recruiting

16

Research Site

Miami, Florida, United States, 33175

Actively Recruiting

17

Research Site

Orlando, Florida, United States, 32819

Actively Recruiting

18

Research Site

Plantation, Florida, United States, 33324

Not Yet Recruiting

19

Research Site

Tampa, Florida, United States, 33607

Actively Recruiting

20

Research Site

Winter Park, Florida, United States, 32789

Actively Recruiting

21

Research Site

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

22

Research Site

Henderson, Nevada, United States, 89052

Actively Recruiting

23

Research Site

Northfield, New Jersey, United States, 08225

Actively Recruiting

24

Research Site

Union City, New Jersey, United States, 07087

Not Yet Recruiting

25

Research Site

New Hyde Park, New York, United States, 11042

Actively Recruiting

26

Research Site

The Bronx, New York, United States, 10459

Actively Recruiting

27

Research Site

Oklahoma City, Oklahoma, United States, 73103

Withdrawn

28

Research Site

Oklahoma City, Oklahoma, United States, 73111

Actively Recruiting

29

Research Site

DuBois, Pennsylvania, United States, 15801

Actively Recruiting

30

Research Site

Warwick, Rhode Island, United States, 02886

Actively Recruiting

31

Research Site

Greenville, South Carolina, United States, 29607

Actively Recruiting

32

Research Site

Houston, Texas, United States, 77099

Not Yet Recruiting

33

Research Site

McKinney, Texas, United States, 75069

Actively Recruiting

34

Research Site

San Antonio, Texas, United States, 78251

Actively Recruiting

35

Research Site

Dimitrovgrad, Bulgaria, 6400

Not Yet Recruiting

36

Research Site

Haskovo, Bulgaria, 6300

Not Yet Recruiting

37

Research Site

Pleven, Bulgaria, 5800

Not Yet Recruiting

38

Research Site

Plovdiv, Bulgaria, 4002

Actively Recruiting

39

Research Site

Plovdiv, Bulgaria, 4023

Not Yet Recruiting

40

Research Site

Rousse, Bulgaria, 7002

Actively Recruiting

41

Research Site

Sofia, Bulgaria, 1142

Actively Recruiting

42

Research Site

Sofia, Bulgaria, 1431

Actively Recruiting

43

Research Site

Stara Zagora, Bulgaria, 6000

Actively Recruiting

44

Research Site

Stara Zagora, Bulgaria, 6000

Not Yet Recruiting

45

Research Site

Edmonton, Alberta, Canada, T6G 2C8

Withdrawn

46

Research Site

Kamloops, British Columbia, Canada, V2C 5T1

Actively Recruiting

47

Research Site

Vancouver, British Columbia, Canada, V5Z 1M9

Actively Recruiting

48

Research Site

Ajax, Ontario, Canada, L1S 2J5

Actively Recruiting

49

Research Site

Toronto, Ontario, Canada, M5T 3A9

Actively Recruiting

50

Research Site

Windsor, Ontario, Canada, N8X 1T3

Actively Recruiting

51

Research Site

Québec, Quebec, Canada, G1G 3Y8

Actively Recruiting

52

Research Site

Sainte-Foy, Quebec, Canada, G1V 4G5

Actively Recruiting

53

Research Site

Beijing, China, 100020

Actively Recruiting

54

Research Site

Beijing, China, 100044

Actively Recruiting

55

Research Site

Beijing, China, 102218

Actively Recruiting

56

Research Site

Changsha, China, 410004

Actively Recruiting

57

Research Site

Chongqing, China, 400042

Actively Recruiting

58

Research Site

Fuzhou, China, 350001

Not Yet Recruiting

59

Research Site

Fuzhou, China, 350005

Not Yet Recruiting

60

Research Site

Fuzhou, China, 350008

Actively Recruiting

61

Research Site

Guangzhou, China, 510120

Actively Recruiting

62

Research Site

Guangzhou, China, 510180

Actively Recruiting

63

Research Site

Hangzhou, China, 31000

Actively Recruiting

64

Research Site

Hangzhou, China, 310014

Actively Recruiting

65

Research Site

Hefei, China, 230061

Actively Recruiting

66

Research Site

Huizhou, China, 516002

Actively Recruiting

67

Research Site

Jinan, China, 250021

Actively Recruiting

68

Research Site

Linyi, China, 276100

Not Yet Recruiting

69

Research Site

Ningbo, China, 315020

Actively Recruiting

70

Research Site

Qinhuangdao, China

Actively Recruiting

71

Research Site

Shanghai, China, 200080

Actively Recruiting

72

Research Site

Shanghai, China, 200433

Actively Recruiting

73

Research Site

Wenzhou, China, 325027

Actively Recruiting

74

Research Site

Wuhan, China, 430030

Actively Recruiting

75

Research Site

Xuzhou, China, 221000

Actively Recruiting

76

Research Site

Yinchuan, China, 750004

Actively Recruiting

77

Research Site

Zhengzhou, China, 450000

Actively Recruiting

78

Research Site

Bayonne, France, 64109

Actively Recruiting

79

Research Site

Créteil, France, 94010

Actively Recruiting

80

Research Site

La Tronche, France, 38043

Actively Recruiting

81

Research Site

Lyon, France, 69317

Actively Recruiting

82

Research Site

Montpellier, France, 34295

Actively Recruiting

83

Research Site

Pessac, France, F-33604

Actively Recruiting

84

Research Site

Suresnes, France, 92150

Actively Recruiting

85

Research Site

Toulouse, France, 31059

Actively Recruiting

86

Research Site

Villeurbanne, France, 69100

Actively Recruiting

87

Research Site

Berlin, Germany, 10367

Actively Recruiting

88

Research Site

Berlin, Germany, 10717

Actively Recruiting

89

Research Site

Bonn, Germany, 53119

Not Yet Recruiting

90

Research Site

Cottbus, Germany, 03050

Actively Recruiting

91

Research Site

Delitzsch, Germany, 4509

Withdrawn

92

Research Site

Frankfurt am Main, Germany, 60389

Not Yet Recruiting

93

Research Site

Geesthacht, Germany, 21502

Actively Recruiting

94

Research Site

Hemer, Germany, 58675

Not Yet Recruiting

95

Research Site

Landsberg, Germany, 86899

Not Yet Recruiting

96

Research Site

Langen, Germany, 63225

Not Yet Recruiting

97

Research Site

Lübeck, Germany, 23552

Actively Recruiting

98

Research Site

Mönchengladbach, Germany, 41063

Not Yet Recruiting

99

Research Site

München, Germany, 81377

Suspended

100

Research Site

München-Pasing, Germany, 81241

Not Yet Recruiting

101

Research Site

Neu-Isenburg, Germany, 63263

Not Yet Recruiting

102

Research Site

Wiesbaden, Germany, 65183

Actively Recruiting

103

Research Site

Witten, Germany, 58452

Not Yet Recruiting

104

Research Site

Zossen, Germany, 15806

Not Yet Recruiting

105

Research Site

Hong Kong, Hong Kong, 999077

Withdrawn

106

Research Site

Pok Fu Lam, Hong Kong, 999077

Actively Recruiting

107

Research Site

Shatin, Hong Kong, 0000

Actively Recruiting

108

Research Site

Ballinasloe, Ireland, H53 T971

Actively Recruiting

109

Research Site

Cork, Ireland, T12 DFK4

Actively Recruiting

110

Research Site

Dublin, Ireland, D15 X40D

Actively Recruiting

111

Research Site

Moneymore, Ireland, A92 VW28

Actively Recruiting

112

Research Site

Bari, Italy, 70124

Not Yet Recruiting

113

Research Site

Bergamo, Italy, 24127

Actively Recruiting

114

Research Site

Brescia, Italy, 25123

Actively Recruiting

115

Research Site

Cagliari, Italy, 09122

Actively Recruiting

116

Research Site

Catanzaro, Italy, 88100

Actively Recruiting

117

Research Site

Genoa, Italy, 16132

Actively Recruiting

118

Research Site

Milan, Italy, 20122

Actively Recruiting

119

Research Site

Modena, Italy, 41124

Withdrawn

120

Research Site

Montebelluna, Italy, 31044

Actively Recruiting

121

Research Site

Naples, Italy, 80131

Actively Recruiting

122

Research Site

Roma, Italy, 00161

Actively Recruiting

123

Research Site

Roma, Italy, 00168

Actively Recruiting

124

Research Site

Rozzano, Italy, 20089

Actively Recruiting

125

Research Site

Verona, Italy, 37124

Actively Recruiting

126

Research Site

Lørenskog, Norway, N-1478

Actively Recruiting

127

Research Site

Alcorcón, Spain, 28922

Actively Recruiting

128

Research Site

Alzira (Valencia), Spain, 46600

Actively Recruiting

129

Research Site

Badalona, Spain, 08916

Actively Recruiting

130

Research Site

Barakaldo, Spain, 48902

Actively Recruiting

131

Research Site

Barcelona, Spain, 08025

Actively Recruiting

132

Research Site

Barcelona, Spain, 08035

Actively Recruiting

133

Research Site

Burgos, Spain, 09006

Actively Recruiting

134

Research Site

Cáceres, Spain, 10003

Actively Recruiting

135

Research Site

Granada, Spain, 18014

Actively Recruiting

136

Research Site

Jerez de la Frontera, Spain, 11407

Actively Recruiting

137

Research Site

Lugo, Spain, 27003

Actively Recruiting

138

Research Site

Madrid, Spain, 28034

Actively Recruiting

139

Research Site

Madrid, Spain, 28041

Actively Recruiting

140

Research Site

Madrid, Spain, 28050

Not Yet Recruiting

141

Research Site

Marbella, Spain, 29600

Actively Recruiting

142

Research Site

Marbella, Spain, 29603

Actively Recruiting

143

Research Site

Málaga, Spain, 29010

Actively Recruiting

144

Research Site

Mérida, Spain, 06800

Actively Recruiting

145

Research Site

Palma de Mallorca, Spain, 7120

Actively Recruiting

146

Research Site

Santander, Spain, 39008

Actively Recruiting

147

Research Site

Aarau, Switzerland, 5001

Actively Recruiting

148

Research Site

Basel, Switzerland, 4031

Actively Recruiting

149

Research Site

Lausanne, Switzerland, 1011

Actively Recruiting

150

Research Site

Sankt Gallen, Switzerland, 9007

Actively Recruiting

151

Research Site

Sion, Switzerland, 1951

Actively Recruiting

152

Research Site

Belfast, United Kingdom, BT9 7AB

Actively Recruiting

153

Research Site

Birmingham, United Kingdom, B9 5SS

Actively Recruiting

154

Research Site

Bradford, United Kingdom, BD9 6RJ

Actively Recruiting

155

Research Site

Bristol, United Kingdom, BS10 5NB

Actively Recruiting

156

Research Site

Chorley, United Kingdom, PR7 1PP

Actively Recruiting

157

Research Site

Leeds, United Kingdom, LS9 7TF

Actively Recruiting

158

Research Site

Liverpool, United Kingdom, L7 8XP

Not Yet Recruiting

159

Research Site

Nottingham, United Kingdom, NG7 2UH

Withdrawn

160

Research Site

Portsmouth, United Kingdom, PO6 3LY

Withdrawn

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment | DecenTrialz